LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 130 filers reported holding LOXO ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 2.66 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $279,766,000 | -14.3% | 1,997,330 | +4.6% | 0.04% | +2.7% |
Q3 2018 | $326,345,000 | -18.2% | 1,910,350 | -17.0% | 0.04% | -19.6% |
Q2 2018 | $399,126,000 | -20.2% | 2,300,702 | -46.9% | 0.05% | -22.0% |
Q1 2018 | $500,114,000 | +32.3% | 4,334,871 | -3.5% | 0.06% | +34.1% |
Q4 2017 | $378,021,000 | -8.4% | 4,490,625 | +0.3% | 0.04% | -12.0% |
Q3 2017 | $412,505,000 | +17.0% | 4,477,904 | +1.9% | 0.05% | +13.6% |
Q2 2017 | $352,420,000 | +113.5% | 4,394,827 | +12.1% | 0.04% | +109.5% |
Q1 2017 | $165,039,000 | +58.0% | 3,922,013 | +20.6% | 0.02% | +50.0% |
Q4 2016 | $104,429,000 | +22.7% | 3,251,707 | +0.1% | 0.01% | +27.3% |
Q3 2016 | $85,076,000 | +14.7% | 3,249,649 | +1.6% | 0.01% | +10.0% |
Q2 2016 | $74,173,000 | -8.0% | 3,199,856 | +8.6% | 0.01% | -9.1% |
Q1 2016 | $80,589,000 | -3.5% | 2,947,659 | +0.5% | 0.01% | 0.0% |
Q4 2015 | $83,482,000 | +1974.1% | 2,934,365 | +1174.2% | 0.01% | +1000.0% |
Q3 2015 | $4,025,000 | – | 230,286 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 3,438,920 | $289,488,000 | 57.19% |
DAFNA Capital Management LLC | 296,000 | $24,917,000 | 13.42% |
Casdin Capital, LLC | 360,000 | $30,305,000 | 7.38% |
Opaleye Management Inc. | 176,300 | $14,841,000 | 4.75% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 574,495 | $48,361,000 | 1.84% |
SECTORAL ASSET MANAGEMENT INC | 152,185 | $12,811,000 | 1.60% |
AWM Investment Company, Inc. | 85,000 | $7,155,000 | 1.39% |
Eventide Asset Management | 285,000 | $23,991,000 | 1.25% |
Rock Springs Capital Management LP | 310,000 | $26,096,000 | 1.18% |
Crawford Lake Capital Management, LLC | 53,420 | $4,497,000 | 1.06% |